Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $38.73 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 07/24/15 All times are local (Market data is delayed by at least 15 minutes).

olympus corp (OCPNF) Snapshot

Open
$38.73
Previous Close
$38.73
Day High
$38.73
Day Low
$38.73
52 Week High
07/24/15 - $38.73
52 Week Low
10/31/14 - $35.30
Market Cap
13.3B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
342.7M
EX-Date
03/29/16
P/E TM
--
Dividend
$17.00
Dividend Yield
0.22%
Current Stock Chart for OLYMPUS CORP (OCPNF)

Related News

No related news articles were found.

olympus corp (OCPNF) Related Businessweek News

View More BusinessWeek News

olympus corp (OCPNF) Details

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates in four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others Business. The Medical Business segment provides endoscopy systems comprising videoscopes, video processors, light sources, and liquid crystal display panels; peripheral equipment, such as image recording devices, endoscope cleaning systems, sterilization systems, etc.; surgical video endoscopy systems, peripheral devices for endoscopic surgery, electrosurgical knives, etc.; and endoscopic devices for various diagnostic and treatment procedures, including biopsy forceps, high-frequency polypectomy snares, grasping forceps, stone retrieval and lithotriptor baskets, hemostasis accessories, etc. The Scientific Solutions Business segment offers upright and polarizing microscopes, inverted microscopes, laser confocal microscopes, box-type fluorescence imaging devices, stereo microscopes, fluorescence macro microscopes, microscope digital cameras, imaging software, bio-imaging systems, and virtual slide systems; and metallurgical microscopes, semiconductor inspection microscopes, laser and measuring microscopes, microscopic 3D measurement systems, industrial videoscopes and fiberscopes, industrial rigid scopes, ultrasonic flaw detectors, eddy current flaw detectors, phased array flaw detectors, X-ray diffraction analyzers, and peripheral equipment. The Imaging Business segment offers digital single-lens cameras, compact digital cameras and related products, digital camera lens barrels, and optical components, as well as IC recorders and binoculars. The Others Business segment manufactures biomedical materials, as well as conducts system development and other business activities. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

31,540 Employees
Last Reported Date: 06/26/15
Founded in 1919

olympus corp (OCPNF) Top Compensated Officers

President and Representative Director
Total Annual Compensation: ¥98.6M
Compensation as of Fiscal Year 2015.

olympus corp (OCPNF) Key Developments

Olympus Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2016; Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2015; Revises Earnings Guidance for the Six Months of Fiscal 2016; Reaffirms Earnings Guidance for the Year Ending March 31, 2016

Olympus Corporation provided dividend guidance for the fiscal year ending March 31, 2016. For the year, the company expected dividend of ¥17.00 per share against dividend of ¥10.00 per share a year ago. The company announced consolidated earnings results for the first quarter ended June 30, 2015. For the quarter, the company's net sales were ¥187,572 million compared with ¥167,013 million a year ago. Operating income was ¥17,165 million compared with ¥15,053 million a year ago. Ordinary income was ¥16,679 million compared with ¥11,155 million a year ago. Net income attributable to owners of the parent was ¥16,734 million or ¥48.88 per diluted share compared with ¥8,141 million or ¥23.79 per diluted share a year ago. Income before provision for income taxes was ¥14,258 million compared with ¥11,155 million a year ago. Cash flow from operating activities benefited from cash generated from favorable Medical business performance and also on the further collection on accounts receivables. This is basically 1.5x over the same period previous year at ¥30.5 billion. Cash flow from investing activities relating from capital expenditure was negative ¥10.4 billion. For the six months of fiscal 2016, the company forecasts net sales of ¥390,000 million, operating income of ¥45,000 million, ordinary income of ¥37,000 million, net income attributable to owners of the parent of ¥28,000 million or ¥81.81 per share compared to previous guidance of net sales of ¥390,000 million, operating income of ¥45,000 million, ordinary income of ¥37,000 million, net income attributable to owners of the parent of ¥24,000 million or ¥70.13 per share. For the year ending March 31, 2016, the company forecasts net sales of ¥810,000 million, operating income of ¥100,000 million, ordinary income of ¥86,000 million, net income attributable to owners of the parent of ¥56,000 million or ¥163.63 per share compared to previous guidance of net sales of ¥810,000 million, operating income of ¥100,000 million, ordinary income of ¥86,000 million, net income attributable to owners of the parent of ¥56,000 million or ¥163.63 per share.

Olympus Corporation to Report Q1, 2016 Results on Aug 06, 2015

Olympus Corporation announced that they will report Q1, 2016 results on Aug 06, 2015

Olympus Corporation, Q1 2016 Earnings Call, Aug 06, 2015

Olympus Corporation, Q1 2016 Earnings Call, Aug 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCPNF:US $38.73 USD 0.00

OCPNF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AMETEK Inc $51.93 USD -0.85
CR Bard Inc $187.93 USD -2.46
Hoya Corp ¥4,277 JPY -94.50
Smith & Nephew PLC 1,150 GBp -16.00
Terumo Corp ¥3,135 JPY -55.00
View Industry Companies
 

Industry Analysis

OCPNF

Industry Average

Valuation OCPNF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 3.8x
Price/Cash Flow 37.1x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OLYMPUS CORP, please visit www.olympus-global.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.